Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hydrogen Sulfide as Prognostic Factor (H2S-1)

This study has been completed.
Information provided by (Responsible Party):
Podbregar Matej, University Medical Centre Ljubljana Identifier:
First received: March 12, 2010
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):